公开(公告)号：US20130315877A1

公开(公告)日：2013-11-28

申请号：US13755517

申请日：2013-01-31

申请人： UNHWA CORPORATION

发明人： JOONG HYUN PARK ,  MIN JUNG LIM ,  IL SEOK OH ,  DAE HEE LEE ,  JUNG CHANG LEE ,  EUN KYONG LEE ,  YOUNG WOO JIN

IPC分类号： A61K36/13

CPC分类号： A61K36/13

摘要： The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Taxus cambium- or procambium-derived cell line; a lysate thereof; an extract thereof; or a culture medium thereof. The cell line, the lysate, the extract, and the culture medium has minimized side effects compared to the conventional therapeutic drugs, is safe to the human body, is involved directly in the growth of cancer to induce cancer cell death, and shows anticancer activity of inhibiting angiogenesis occurring in carcinogenesis. Accordingly, the cell line, the lysate, the extract and the culture medium is useful for the prevention, treatment and alleviation of cancer.

摘要翻译： 本发明涉及一种用于预防或治疗癌症的组合物，其含有作为有效成分的红豆杉形成层或原生动物来源的细胞系; 其裂解物; 其提取物; 或其培养基。 细胞系，裂解物，提取物和培养基与常规治疗药物相比具有最小化的副作用，对人体是安全的，直接参与癌症的生长以诱导癌细胞死亡，并且显示抗癌活性 抑制致癌作用中发生的血管生成。 因此，细胞系，裂解物，提取物和培养基可用于预防，治疗和缓解癌症。